SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2001 / Cilt: 7 - Sayı: 5

Acute renal failure after suicidal use of high dose tripotassium dicitrato bismutate

Suicid amacıyla alınan aşırı doz tripotasyum dicitrato bismutate sonrası gelişen akut böbrek yetmezliği

Ali ÖZDEMİR
A. Tayfun KESKİN
Pınar SEYMEN
Fügen AKAR
Yıldız ÖZEL
Pages
601–603
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Tripotassium Disitrato Bismutate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is well known for many years that bismuth could cause various toxicities primarily nephrotoxicity, hepatotoxicicity, and neurotoxicity.
📊
Key Findings & Data:It is relatively new to encounter nephrotoxicity due to Tripotassium Disitrato Bismutate usage in gastric and duodenal ulcus.
💡
Conclusion & Impact:Tripotassium Disitrato Bismutate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İlaç toksisitesi · Bizmut · Böbrek yetmezliği

Abstract

It is well known for many years that bismuth could cause various toxicities primarily nephrotoxicity, hepatotoxicicity, and neurotoxicity. It is relatively new to encounter nephrotoxicity due to Tripotassium Disitrato Bismutate usage in gastric and duodenal ulcus. There are four nephrotoxicity cases reported at literature due to high dose. Tripotassium Disitrato Bismutate.

Özet

Çeşitli bizmut tuzları ile nefrotoksisite, hepatotoksisite ve nörotoksisite başta olmak üzere çeşitli toksisiteler uzun yıllardır bilinmektedir. Gastrik ve duodenal ülser tedavisinde kullnılan Tripotasyum dicitrato bismutata (TDB) bağlı nefrotoksisite ile tanışılması nispeten yenidir. Literatürde şimdiye kadar yüksek doz TDB'ye bağlı 4 nefrotoksisite olgusu bildirilmiştir.

🔖

Cite This Article

ÖZDEMİR, A., KESKİN, A. T., SEYMEN, P., AKAR, F., ÖZEL, Y. (2001). Acute renal failure after suicidal use of high dose tripotassium dicitrato bismutate. Medical Network Klinik Bilimler ve Doktor, Cilt: 7 - Sayı: 5, 601–603. https://ajindex.com/articles/278721

References (8)

  1. Bader J.P. The safety profile of De-Noel. Digestion 1987; 37:(suppl.2) 53-59.
  2. Urizar R, Vernier RL: Bismuth nephropaty. Jama 1966; 198: 187-189.
  3. Randall RE, Osterhoff RJ, Bakerman S, Setter JG. Bismuth nephrotoxicity. Ann Intern Med 1972; 77:481-482.
  4. Taylor EG, Klenerman P.: Acute renal feilure after colloidal bismuth subcitrate overdose. Lancet 1990; 335:670-71.
  5. Huwez F, Pall A, Lyons D, Stewart MJ. Acute renal failure after overdose of colloidal bismuth subcitrate. Lancet 1992; 340:21 Akpolat İ, Kahraman H, Arık N, Akpolat T, Kandemir B, Cengiz K. Yüksek doz kolloidal bizmuta bağlı Akut tubuler nekroz. 13. Ulusal böbrek hastalıkları, dializ ve transplantasyon kongresi 22-26 Ekim, 1996,
  6. İstanbul.
  7. Gavey CJ, Szeto ML, Nwokolo CU, Sercombe J, Pounder RE. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Alyment Pharmacol Ther 1989; 3:21-28.
  8. Hepse W, Staal HJM, Hall DWR. Bismuth absorption from the colloidal subcitrate. Lancet 1988; 26:1258 Mclean AJ, Froomes P, McNeil JJ, at al. Bismuth subcitrate handling in man. Am. Society for Clin. Pharmacology and Therapeutics Eighty-ninth Annual Meeting 1988; March 9-11.